Study Outcome | Coefficient | Standard Error | t | P > |t| | 95% Confidence Interval |
---|---|---|---|---|---|
Overall Survival | 0.42 | 0.56 | 0.74 | 0.47 | −0.82~1.66 |
Disease-Free Survival | −0.43 | 0.53 | −0.82 | 0.44 | −1.64~0.78 |
Locoregional Recurrence | −0.39 | 0.33 | −1.19 | 0.26 | −1.11~0.33 |
Distant Metastasis | 0.42 | 0.25 | 1.67 | 0.13 | −0.16~1.00 |
Acute Skin Toxicity | 1.57 | 0.64 | 2.45 | 0.02 | 0.24~2.89 |
Acute Lung Toxicity | −0.50 | 0.49 | −1.01 | 0.34 | −1.63~0.64 |
Late Skin Toxicity | −0.15 | 0.67 | −0.23 | 0.83 | −1.86~1.55 |
Lymphedema | 0.41 | 0.38 | 1.07 | 0.32 | −0.50~1.32 |
Shoulder Restriction | 0.39 | 1.30 | 0.30 | 0.79 | −5.19~5.98 |
Late Cardiac Related Toxicity | −0.89 | 0.97 | −0.92 | 0.41 | −3.59~1.80 |